Neuralstem, Inc. (NASDAQ:CUR) announced publication of manuscript in Stem Cells Translational Medicine

Neuralstem, Inc. (NASDAQ:CUR) announced the publication of a manuscript in Stem Cells Translational Medicine describing the results of an open label Phase 1 clinical trial evaluating the feasibility and safety of transplantation of its lead stem cell asset, NSI-566, for the treatment of motor deficits due to ischemic stroke.

The insider ownership percentage is the key indicator, can be used by investors, to measure the outlook of senior management has on their company. Insider ownership for the CUR is 13.52%. Institutional ownership refers to the ownership stake in a company that is held by large financial organizations, pension funds or endowments. The Institutional ownership for the CUR is 5.20%.

Insider trading is the buying or selling of any publicly traded company’s stock and this can be done by someone who has non-public, material information about that CUR. Insider trading can be illegal or legal depending on when the insider makes the trade. It is illegal when the material information is still non-public.

Institutional ownership is the amount of a Neuralstem, Inc. (NASDAQ:CUR)’s available stock owned by mutual or pension funds, insurance companies, investment firms, private foundations, endowments or other large entities that actually manage the funds on the behalf of others, so its an interesting element for the traders to note it, and the Institutional ownership for the CUR is -66.99%.

a Healthcare sector firm, Neuralstem, Inc. (NASDAQ:CUR) stock advanced 2.07% on Monday and when day-trade ended the stock finally concluded at $0.30 and number of shares that changed hands during the day are 200272. The number of shares CUR stock currently held by all its shareholders are 19.05 and floated shares, the number of shares are available for trading in an open market on last trading day are 15.72. The average volume of shares for 3 months is 172.70 and CUR stock value has moved between $0.25 – 1.58 in last one year.

The Neuralstem, Inc. (NASDAQ:CUR)’s latest earnings date is 8/13/2019. The Gross margin is the difference between the revenue and the cost of goods sold (COGS), divided by revenue. In other words, Gross Margin is a percentage value, while Gross Profit is a monetary value. The stock has gained -4.15% in 2019 to date.

See also  Dental Veneers Before and After: All That You Should Know

[finviz ticker=CUR]

U.S. traded shares of Neuralstem, Inc. (NASDAQ:CUR)’s monthly stock performance is -32.71%, the quarterly performance is -34.76%, the half year performance is calculated as -6.95%. The yearly performance of CUR is -73.68%.

The higher the volatility, the riskier the security. For example, when the stock market rises and falls more than one percent over a sustained period of time, it is called a “volatile” market, if the stock price stays relatively stable, the security has low volatility. The Neuralstem, Inc. (NASDAQ:CUR) weekly volatility is measured as 13.76% and monthly volatility measured as 10.71%.

Return on assets (ROA) is a main indicator of how profitable a company is relative to its total assets. CUR return on assets is -78.40%, the return on equity (ROE) of the Neuralstem, Inc. (NASDAQ:CUR) is -118.20%, while the most important return on investment is calculates as a percentage and is typically used for personal financial decisions, and CUR return on investment is -137.70%.

The price to sales ratio is 19.06, and price to book ratio is 1.67.

Analysts mean target price for Neuralstem, Inc. (NASDAQ:CUR) is $26.00. The current share price indicates that stock is -81.13% away from its one year high and is moving 20.04% ahead of its 52-week low. CUR’s distance from 20 day simple moving average is -17.61% and distance from 50-Day simple moving average is -30.46%.

Leave a Reply